TFF Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q2 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
TFF Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q2 2022 to Q3 2024.
  • TFF Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $58K, a 58.3% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $58K -$81.2K -58.3% Sep 30, 2024 10-Q 2024-11-20
Q2 2024 $78.9K -$79.6K -50.2% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $99.4K -$78K -44% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $120K -$76.5K -39% Dec 31, 2023 10-Q 2024-11-20
Q3 2023 $139K -$75K -35% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $159K -$73.6K -31.7% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $177K Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $196K Dec 31, 2022 10-K 2024-03-28
Q3 2022 $214K Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $232K Jun 30, 2022 10-Q 2022-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.